Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Avacopan 1.4.3 Immune Globulin 1.4.4 Rituximab Biosimilar 1.4.5 Others 1.5 Market by Application 1.5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Microscopic Polyangiitis (MPA) Treatment Market Perspective (2015-2026) 2.2 Microscopic Polyangiitis (MPA) Treatment Growth Trends by Regions 2.2.1 Microscopic Polyangiitis (MPA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Microscopic Polyangiitis (MPA) Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Microscopic Polyangiitis (MPA) Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Market Size 3.1.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue (2015-2020) 3.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio 3.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019 3.3 Microscopic Polyangiitis (MPA) Treatment Key Players Head office and Area Served 3.4 Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service 3.5 Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Type (2015-2020) 4.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Type (2021-2026) 5 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Application (2015-2026) 5.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 5.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 6.2 Microscopic Polyangiitis (MPA) Treatment Key Players in North America (2019-2020) 6.3 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 6.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 7.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Europe (2019-2020) 7.3 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 7.4 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 8 China 8.1 China Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 8.2 Microscopic Polyangiitis (MPA) Treatment Key Players in China (2019-2020) 8.3 China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 8.4 China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 9.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Japan (2019-2020) 9.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 9.4 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 10.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 11 India 11.1 India Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 11.2 Microscopic Polyangiitis (MPA) Treatment Key Players in India (2019-2020) 11.3 India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 11.4 India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2020) 12.2 Microscopic Polyangiitis (MPA) Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) 12.4 Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Celltrion Inc 13.1.1 Celltrion Inc Company Details 13.1.2 Celltrion Inc Business Overview and Its Total Revenue 13.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction 13.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)) 13.1.5 Celltrion Inc Recent Development 13.2 ChemoCentryx Inc 13.2.1 ChemoCentryx Inc Company Details 13.2.2 ChemoCentryx Inc Business Overview and Its Total Revenue 13.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction 13.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) 13.2.5 ChemoCentryx Inc Recent Development 13.3 Sandoz International GmbH 13.3.1 Sandoz International GmbH Company Details 13.3.2 Sandoz International GmbH Business Overview and Its Total Revenue 13.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction 13.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) 13.3.5 Sandoz International GmbH Recent Development 13.4 Teijin Pharma Ltd 13.4.1 Teijin Pharma Ltd Company Details 13.4.2 Teijin Pharma Ltd Business Overview and Its Total Revenue 13.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction 13.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) 13.4.5 Teijin Pharma Ltd Recent Development 13.5 TTY Biopharm Company Ltd 13.5.1 TTY Biopharm Company Ltd Company Details 13.5.2 TTY Biopharm Company Ltd Business Overview and Its Total Revenue 13.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction 13.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) 13.5.5 TTY Biopharm Company Ltd Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Microscopic Polyangiitis (MPA) Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue Table 3. Ranking of Global Top Microscopic Polyangiitis (MPA) Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Avacopan Table 6. Key Players of Immune Globulin Table 7. Key Players of Rituximab Biosimilar Table 8. Key Players of Others Table 9. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2015-2020) Table 13. Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Microscopic Polyangiitis (MPA) Treatment Market Growth Strategy Table 19. Main Points Interviewed from Key Microscopic Polyangiitis (MPA) Treatment Players Table 20. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Players (2015-2020) (Million US$) Table 21. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players (2015-2020) Table 22. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019) Table 23. Global Microscopic Polyangiitis (MPA) Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service Table 26. Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 29. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Type (2015-2020) Table 30. Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type (2021-2026) Table 31. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2015-2020) Table 32. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 33. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2021-2026) Table 34. North America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 35. North America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 36. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 37. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 38. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 39. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 40. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 42. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 43. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 44. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 45. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 46. China Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 47. China Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 48. China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 49. China Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 50. China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 51. China Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 52. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 54. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 55. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 56. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 57. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 60. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 62. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 64. India Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 65. India Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 66. India Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 67. India Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 68. India Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 69. India Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 70. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Microscopic Polyangiitis (MPA) Treatment Market Share (2019-2020) Table 72. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020) Table 74. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020) Table 76. Celltrion Inc Company Details Table 77. Celltrion Inc Business Overview Table 78. Celltrion Inc Product Table 79. Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$) Table 80. Celltrion Inc Recent Development Table 81. ChemoCentryx Inc Company Details Table 82. ChemoCentryx Inc Business Overview Table 83. ChemoCentryx Inc Product Table 84. ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$) Table 85. ChemoCentryx Inc Recent Development Table 86. Sandoz International GmbH Company Details Table 87. Sandoz International GmbH Business Overview Table 88. Sandoz International GmbH Product Table 89. Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$) Table 90. Sandoz International GmbH Recent Development Table 91. Teijin Pharma Ltd Company Details Table 92. Teijin Pharma Ltd Business Overview Table 93. Teijin Pharma Ltd Product Table 94. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$) Table 95. Teijin Pharma Ltd Recent Development Table 96. TTY Biopharm Company Ltd Company Details Table 97. TTY Biopharm Company Ltd Business Overview Table 98. TTY Biopharm Company Ltd Product Table 99. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (Million US$) Table 100. TTY Biopharm Company Ltd Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type: 2020 VS 2026 Figure 2. Avacopan Features Figure 3. Immune Globulin Features Figure 4. Rituximab Biosimilar Features Figure 5. Others Features Figure 6. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Others Case Studies Figure 10. Microscopic Polyangiitis (MPA) Treatment Report Years Considered Figure 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions: 2020 VS 2026 Figure 13. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players in 2019 Figure 16. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019 Figure 18. North America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Celltrion Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) Figure 27. ChemoCentryx Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) Figure 29. Sandoz International GmbH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) Figure 31. Teijin Pharma Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) Figure 33. TTY Biopharm Company Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) Figure 35. Bottom-up and Top-down Approaches for This Report Figure 36. Data Triangulation Figure 37. Key Executives Interviewed

Celltrion Inc ChemoCentryx Inc Sandoz International GmbH Teijin Pharma Ltd TTY Biopharm Company Ltd